Technical Analysis for CTXR - Citius Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 1.28 -9.86% -0.14
CTXR closed down 9.86 percent on Friday, March 22, 2019, on 1.12 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical CTXR trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 MACD Bearish Signal Line Cross Bearish 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 21 NR7 Range Contraction -9.86%
Mar 21 Wide Bands Range Expansion -9.86%
Mar 20 Bearish Engulfing Bearish -11.11%
Mar 20 Wide Bands Range Expansion -11.11%
Mar 19 NR7 Range Contraction -12.33%
Mar 19 Upper Bollinger Band Walk Strength -12.33%

Older signals for CTXR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care, and prescription products. Its product candidates include Mino-Lok and Hydrocortisone-Lidocaine Cream. The Company's Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. The Company's Hydrocortisone-Lidocaine topical formulation provides anti-inflammation and anesthetic relief to persons suffering from hemorrhoids. Its Mino-Lok product for the treatment of catheter related bloodstream infections has completed Phase IIb and is entering Phase III trials. It is reformulating Hydrocortisone-Lidocaine product and will be entering Phase IIb trials in 2017. As of September 30, 2016, the Company had not generate any revenues.
Medicine Medical Specialties Pharmaceutical Drugs Catheter Cancer Care Care Products Prescription Products Acetamides Lidocaine
Is CTXR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.25
52 Week Low 0.8582
Average Volume 126,243
200-Day Moving Average 1.5838
50-Day Moving Average 1.15
20-Day Moving Average 1.309
10-Day Moving Average 1.402
Average True Range 0.1061
ADX 46.96
+DI 25.1298
-DI 15.4365
Chandelier Exit (Long, 3 ATRs ) 1.2717
Chandelier Exit (Short, 3 ATRs ) 1.3383
Upper Bollinger Band 1.515
Lower Bollinger Band 1.103
Percent B (%b) 0.43
BandWidth 31.474408
MACD Line 0.0779
MACD Signal Line 0.0814
MACD Histogram -0.0035
Fundamentals Value
Market Cap 10.56 Million
Num Shares 8.25 Million
EPS -1.98
Price-to-Earnings (P/E) Ratio -0.65
Price-to-Sales 0.00
Price-to-Book 1.16
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.53
Resistance 3 (R3) 1.56 1.50 1.49
Resistance 2 (R2) 1.50 1.44 1.49 1.47
Resistance 1 (R1) 1.39 1.40 1.36 1.36 1.46
Pivot Point 1.34 1.34 1.32 1.32 1.34
Support 1 (S1) 1.22 1.27 1.20 1.20 1.10
Support 2 (S2) 1.17 1.23 1.16 1.09
Support 3 (S3) 1.06 1.17 1.07
Support 4 (S4) 1.03